http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03275621-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b235c7bee2e6022bcf632b6e260eebaa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 1990-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea3fc7d9f614cfca80e6cac54d2d3d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8127de9773f6fe92415e69f99c020371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50cd838f33d31279c2cc36dae4054575
publicationDate 1991-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03275621-A
titleOfInvention Preparation for external application and its production
abstract PURPOSE: To prepare a preparation for external application having enhanced penetrating rate through the skin by including a nonsteroidal antiinflammatory compound and a specific fatty acid (ester). CONSTITUTION: This preparation for external application used as a cream, a plaster, an ointment or a gel includes (A) an active ingredient selected from 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide-1, 1-dioxide (pyroxyam) of formula I, α-(6-methoxy)naphthyl-propionic acid (naproxen) of formula II and α-(4-isobutyl)phenyl-propionic acid (ibprofen) of formula III, a salt of these three compounds, and diethylammonium salt of 2-[(2,6- dichloroanilino)phenyl]acetic acid (dichlorofenac) of formula IV, and (B) a 4-30C fatty acid, or an alkyl and an alkenyl ester thereof as a transdarmal penetration enhancer.
priorityDate 1989-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232718098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15416243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229901650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226404047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18939913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227610165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232016234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13748619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395154

Total number of triples: 43.